BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16484903)

  • 1. Genetic research and testing in critical care: surrogates' perspective.
    Freeman BD; Kennedy CR; Coopersmith CM; Zehnbauer BA; Buchman TG
    Crit Care Med; 2006 Apr; 34(4):986-94. PubMed ID: 16484903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate consent for genomics research in intensive care.
    Shelton AK; Fish AF; Cobb JP; Bachman JA; Jenkins RL; Battistich V; Freeman BD
    Am J Crit Care; 2009 Sep; 18(5):418-26; quiz 427. PubMed ID: 19723862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitute decisions about genetic testing in critical care research: a glimpse behind the curtain.
    Lavery JV; Slutsky AS
    Crit Care Med; 2006 Apr; 34(4):1257-9. PubMed ID: 16550080
    [No Abstract]   [Full Text] [Related]  

  • 4. Decisions to limit life-sustaining treatment for critically ill patients who lack both decision-making capacity and surrogate decision-makers.
    White DB; Curtis JR; Lo B; Luce JM
    Crit Care Med; 2006 Aug; 34(8):2053-9. PubMed ID: 16763515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' and surrogates' perspective on research and testing in critical care.
    Rubulotta F
    Crit Care Med; 2007 Jan; 35(1):328; author reply 328-9. PubMed ID: 17197795
    [No Abstract]   [Full Text] [Related]  

  • 6. The Experience of Surrogate Decision Makers on Being Approached for Consent for Patient Participation in Research. A Multicenter Study.
    Burns KE; Prats CJ; Maione M; Lanceta M; Zubrinich C; Jeffs L; Smith OM;
    Ann Am Thorac Soc; 2017 Feb; 14(2):238-245. PubMed ID: 27849142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate receptivity to participation in critical illness genetic research: aligning research oversight and stakeholder concerns.
    Freeman BD; Butler K; Bolcic-Jankovic D; Clarridge BR; Kennedy CR; LeBlanc J; Chandros Hull S
    Chest; 2015 Apr; 147(4):979-988. PubMed ID: 25340645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of primary surrogate decision makers' knowledge of intensive care.
    Rodriguez RM; Navarrete E; Schwaber J; McKleroy W; Clouse A; Kerrigan SF; Fortman J
    Crit Care Med; 2008 May; 36(5):1633-6. PubMed ID: 18434916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients.
    Kaarlola A; Tallgren M; Pettilä V
    Crit Care Med; 2006 Aug; 34(8):2120-6. PubMed ID: 16763517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical issues concerning genetic testing and screening in public health.
    Hodge JG
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):66-70. PubMed ID: 14755435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who will consent to emergency treatment trials for subarachnoid hemorrhage?
    Del Giudice A; Plaum J; Maloney E; Kasner SE; Le Roux PD; Baren JM
    Acad Emerg Med; 2009 Apr; 16(4):309-15. PubMed ID: 19298620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of relatives of patients in intensive care and emergency departments to surrogate consent to research on incapacitated participants.
    Stephenson AC; Baker S; Zeps N
    Crit Care Resusc; 2007 Mar; 9(1):40-50. PubMed ID: 17352666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical, social and legal implications of genetic testing in liver disease.
    van Leeuwen DJ; Bernat JL
    Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations.
    Shields A; Lerman C; Sullivan P
    Nicotine Tob Res; 2004 Aug; 6(4):675-88. PubMed ID: 15370164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time perspectives of surrogate decision-makers regarding critical illness research: findings of focus group participants.
    Iverson E; Celious A; Kennedy CR; Shehane E; Eastman A; Warren V; Bolcic-Jankovic D; Clarridge B; Freeman BD
    Chest; 2012 Dec; 142(6):1433-1439. PubMed ID: 22677349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research recruitment practices and critically ill patients. A multicenter, cross-sectional study (the Consent Study).
    Burns KE; Zubrinich C; Tan W; Raptis S; Xiong W; Smith O; McDonald E; Marshall JC; Saginur R; Heslegrave R; Rubenfeld G; Cook DJ;
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1212-8. PubMed ID: 23525935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry.
    Rana R; Afessa B; Keegan MT; Whalen FX; Nuttall GA; Evenson LK; Peters SG; Winters JL; Hubmayr RD; Moore SB; Gajic O;
    Crit Care Med; 2006 Jul; 34(7):1892-7. PubMed ID: 16691136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate and patient discrepancy regarding consent for critical care research.
    Newman JT; Smart A; Reese TR; Williams A; Moss M
    Crit Care Med; 2012 Sep; 40(9):2590-4. PubMed ID: 22732283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing: costs and access to intensive care unit care.
    Pinsky MR
    Crit Care Med; 2003 May; 31(5 Suppl):S411-5. PubMed ID: 12771593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' opinions on privacy, consent and the disclosure of health information for medical research.
    Page SA; Mitchell I
    Chronic Dis Can; 2006; 27(2):60-7. PubMed ID: 16867240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.